Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001209191-23-053554

VP, Clinical Trial Operations sold 5,200 shares at $19.11 ($99,351)

  • VP, Clinical Trial Operations acquired 5,200 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Yu Yong · VP, Clinical Trial Operations

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-10-24 Exercise or conversion : show line 1 in the form +5,200 $6.00 $31,200 111,335 D
2023-10-24 Sale : show line 2 in the form −5,200 $19.11 $99,351 106,135 D
Open-market sales · 5,200 sh · avg $19.11 · $99,351

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-10-24 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −5,200 $6.00 2029-09-20 5,200 207,653 D
Loading xslF345X05/doc4.xml…